Evidence map›Paper›PMID 28320450›Full record

ReviewCritical care (London, England)2017

Antiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillation.

Takashi Tagami, Hideo Yasunaga, Hiroyuki Yokota

Registry-linked trialAbstract readReview
In one paragraph

Review in Critical care (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04997980 (aMsa and amiOdarone Study in cArdiaC Arrest), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04997980 completednot on this map

aMsa and amiOdarone Study in cArdiaC Arrest

TypeobservationalSponsorFondazione IRCCS Policlinico San Matteo di PaviaRan2015 to 2023Enrolled629ConditionsOut-Of-Hospital Cardiac ArrestArmsAmiodarone Injection
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Takashi TagamiDepartment of Emergency and Critical Care Medicine, Nippon Medical School, Tama Nagayama Hospital, 2068512, Tama-shi, Tokyo, Japan. t-tagami@nms.ac.jp.
Hideo YasunagaDepartment of Clinical Epidemiology and Health Economics, The University of Tokyo, School of Public Health, Graduate School of Medicine, 1138555, Bunkyo-ku, Tokyo, Japan.
Hiroyuki YokotaDepartment of Emergency and Critical Care Medicine, Nippon Medical School, 1138603, Bunkyo-ku, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency medicine 2017. Other selected articles can be found online at http://ccforum.com/series/annualupdate2017 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901 .

Indexed as

AmiodaroneAnti-Arrhythmia AgentsEmergency Medical ServicesHumansIntensive Care UnitsLidocaineOut-of-Hospital Cardiac ArrestPlacebosPyrimidinonesVentricular FibrillationAmiodaroneAnti-Arrhythmia AgentsLidocainenifekalantPlacebosPyrimidinones

Identifiers

PMID28320450
PMCPMC5360060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.